Literature DB >> 26209682

Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.

Sophie J Smither1, Michelle Nelson1, Lin Eastaugh1, Alejandro Nunez2, Francisco J Salguero3, Mark S Lever1.   

Abstract

Ebola virus (EBOV) causes a highly infectious and lethal hemorrhagic fever in primates with high fatality rates during outbreaks and EBOV may be exploited as a potential biothreat pathogen. There is therefore a need to develop and license appropriate medical countermeasures against this virus. To determine whether the common marmoset (Callithrix jacchus) would be an appropriate model to assess vaccines or therapies against EBOV disease (EVD), initial susceptibility, lethality and pathogenesis studies were performed. Low doses of EBOV-Kikwit, between 4 and 27 times the 50% tissue culture infectious dose, were sufficient to cause a lethal, reproducible infection. Animals became febrile between days 5 and 6, maintaining a high fever before succumbing to EVD between 6 and 8 days after challenge. Typical signs of EVD were observed. Pathogenesis studies revealed that virus was isolated from the lungs of animals beginning on day 3 after challenge and from the liver, spleen and blood beginning on day 5. The most striking features were observed in animals that succumbed to infection, including high viral titers in all organs, increased levels of liver function enzymes and blood clotting times, decreased levels of platelets, multifocal moderate to severe hepatitis, and perivascular edema. © Crown copyright 2015.

Entities:  

Keywords:  Ebola virus; Ebola virus disease; aerosol; animal model; filovirus; human disease correlates; marmoset; nonhuman primate; pathology

Mesh:

Substances:

Year:  2015        PMID: 26209682     DOI: 10.1093/infdis/jiv371

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Authors:  Sophie J Smither; Simon A Weller; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn M O'Brien; Jackie Steward; Steve G Lonsdale; Mark S Lever
Journal:  J Clin Microbiol       Date:  2015-07-15       Impact factor: 5.948

Review 2.  Animal Models of Ebolavirus Infection.

Authors:  Marisa C St Claire; Dan R Ragland; Laura Bollinger; Peter B Jahrling
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

Review 3.  Neglected filoviruses.

Authors:  Robin Burk; Laura Bollinger; Joshua C Johnson; Jiro Wada; Sheli R Radoshitzky; Gustavo Palacios; Sina Bavari; Peter B Jahrling; Jens H Kuhn
Journal:  FEMS Microbiol Rev       Date:  2016-06-05       Impact factor: 16.408

4.  Haemostatic Changes in Five Patients Infected with Ebola Virus.

Authors:  Sophie J Smither; Lyn M O'Brien; Lyn Eastaugh; Tom Woolley; Steve Lever; Tom Fletcher; Kiran Parmar; Beverley J Hunt; Sarah Watts; Emrys Kirkman
Journal:  Viruses       Date:  2019-07-15       Impact factor: 5.048

5.  Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus.

Authors:  Daniel N Wolfe; Marva J Taylor; Amanda G Zarrabian
Journal:  Hum Vaccin Immunother       Date:  2020-04-10       Impact factor: 3.452

Review 6.  The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections.

Authors:  Mark R Hickman; David L Saunders; Catherine A Bigger; Christopher D Kane; Patrick L Iversen
Journal:  PLoS Negl Trop Dis       Date:  2022-03-08

7.  PET imaging of TSPO expression in immune cells can assess organ-level pathophysiology in high-consequence viral infections.

Authors:  Swati Shah; Sanhita Sinharay; Reema Patel; Jeffrey Solomon; Ji Hyun Lee; William Schreiber-Stainthorp; Falguni Basuli; Xiang Zhang; Katie R Hagen; Rebecca Reeder; Paul Wakim; Louis M Huzella; Dragan Maric; Reed F Johnson; Dima A Hammoud
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-06       Impact factor: 12.779

8.  Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study.

Authors:  Hilary Bower; Elizabeth Smout; Mohamed S Bangura; Osman Kamara; Cecilia Turay; Sembia Johnson; Shefali Oza; Francesco Checchi; Judith R Glynn
Journal:  BMJ       Date:  2016-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.